HEU-II-CL1-HLTH-D6-IND
HORIZON EUROPE - HEALTH - Destination 6 - Maintaining an innovative, sustainable and globally competitive health industry
Brief description of the consultancy firm
Calls for proposals under this destination are directed towards the Key Strategic Orientation KSO-A ‘Promoting an open strategic autonomy by leading the development of key digital, enabling and emerging technologies, sectors and value chains’ of Horizon Europe’s Strategic Plan 2021-2024.
Research and innovation supported under this destination should contribute to the impact area ‘A competitive and secure data-economy’ and in particular to the following expected impact, set out in the Strategic Plan for the health cluster: ‘EU health industry is innovative, sustainable and globally competitive thanks to improved up-take of breakthrough technologies and innovations, which makes the EU with its Member States more resilient and less dependent from imports with regard to the access to and supply of critical health technologies’. In addition, research and innovation supported under this destination could also contribute to the following impact areas: ‘Industrial leadership in key and emerging technologies that work for people’, ‘High quality digital services for all’, and ‘Good health and high-quality accessible health care’.
The health industry is a key driver for growth and has the capacity to provide health technologies to the benefit of patients and providers of health care services. The relevant value chains involve a broad variety of key players from supply, demand and regulatory sides.
In addition, the path of innovation in health is long and complex. The development of novel health technologies is generally associated with uncertainties and market barriers due to expensive and risky development (e.g. high attrition rate in pharmaceutical development), high quality and security requirements (e.g. clinical performance, safety, data privacy and cybersecurity) and market specificities (e.g. strong regulation, pricing and reimbursement issues). In addition, the growing concern about environmental issues is putting more pressure on this industry.
Therefore, there is a need for research and innovation integrating various stakeholders to facilitate market access of innovative health technologies (medical technologies, pharmaceuticals, biotechnologies, digital health technologies).
In order to address these challenges, in particular green and digital transitions and proper supply of health technologies and products, destination 6 will focus on research and innovation activities that aim at:
Facilitating the production of pharmaceuticals in compliance with the objectives of the
European Green Deal.
+ Developing methodologies, guidelines and standards, assessment studies, and structuring
activities adapted to digital solutions and interventions for GDPR compliant translation into health care practice, including inter-operability, cyber-security and data confidentiality.
Supporting public authorities with better methodologies and interdisciplinary approaches to assess and value new health technologies and intervention
Basic information
- Funding period: 01.01.2021 - 08.12.2027 [9th EU Funding Period (2021-2027)]
Budget
- MFF Department I. SINGLE MARKET, INNOVATION & DIGITAL
- Already allocated funds 0
- Remaining funds of this period 0
-
Annual budgets:
2021 440000002022 690000002023 560000002024 12000000
Detailed informations
Project conditions
Dates, deadlines and locations
- Time remaining until deadline 12 Month(s) , 30 Day(s) , 0 Hours. , 0 Minutes.
DOCUMENTS
-
there are currently no documents available for this record
Links
-
There are currently no links to this data set